Cargando…
Nanofat: A therapeutic paradigm in regenerative medicine
Adipose tissue is a compact and well-organized tissue containing a heterogeneous cellular population of progenitor cells, including mesenchymal stromal cells. Due to its availability and accessibility, adipose tissue is considered a “stem cell depot.” Adipose tissue products possess anti-inflammator...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641019/ https://www.ncbi.nlm.nih.gov/pubmed/34909120 http://dx.doi.org/10.4252/wjsc.v13.i11.1733 |
_version_ | 1784609426270846976 |
---|---|
author | Jeyaraman, Madhan Muthu, Sathish Sharma, Shilpa Ganta, Charan Ranjan, Rajni Jha, Saurabh Kumar |
author_facet | Jeyaraman, Madhan Muthu, Sathish Sharma, Shilpa Ganta, Charan Ranjan, Rajni Jha, Saurabh Kumar |
author_sort | Jeyaraman, Madhan |
collection | PubMed |
description | Adipose tissue is a compact and well-organized tissue containing a heterogeneous cellular population of progenitor cells, including mesenchymal stromal cells. Due to its availability and accessibility, adipose tissue is considered a “stem cell depot.” Adipose tissue products possess anti-inflammatory, anti-fibrotic, anti-apoptotic, and immunomodulatory effects. Nanofat, being a compact bundle of stem cells with regenerative and tissue remodeling potential, has potential in translational and regenerative medicine. Considering the wide range of applicability of its reconstructive and regenerative potential, the applications of nanofat can be used in various disciplines. Nanofat behaves on the line of adipose tissue-derived mesenchymal stromal cells. At the site of injury, these stromal cells initiate a site-specific reparative response comprised of remodeling of the extracellular matrix, enhanced and sustained angiogenesis, and immune system modulation. These properties of stromal cells provide a platform for the usage of regenerative medicine principles in curbing various diseases. Details about nanofat, including various preparation methods, characterization, delivery methods, evidence on practical applications, and ethical concerns are included in this review. However, appropriate guidelines and preparation protocols for its optimal use in a wide range of clinical applications have yet to be standardized. |
format | Online Article Text |
id | pubmed-8641019 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-86410192021-12-13 Nanofat: A therapeutic paradigm in regenerative medicine Jeyaraman, Madhan Muthu, Sathish Sharma, Shilpa Ganta, Charan Ranjan, Rajni Jha, Saurabh Kumar World J Stem Cells Review Adipose tissue is a compact and well-organized tissue containing a heterogeneous cellular population of progenitor cells, including mesenchymal stromal cells. Due to its availability and accessibility, adipose tissue is considered a “stem cell depot.” Adipose tissue products possess anti-inflammatory, anti-fibrotic, anti-apoptotic, and immunomodulatory effects. Nanofat, being a compact bundle of stem cells with regenerative and tissue remodeling potential, has potential in translational and regenerative medicine. Considering the wide range of applicability of its reconstructive and regenerative potential, the applications of nanofat can be used in various disciplines. Nanofat behaves on the line of adipose tissue-derived mesenchymal stromal cells. At the site of injury, these stromal cells initiate a site-specific reparative response comprised of remodeling of the extracellular matrix, enhanced and sustained angiogenesis, and immune system modulation. These properties of stromal cells provide a platform for the usage of regenerative medicine principles in curbing various diseases. Details about nanofat, including various preparation methods, characterization, delivery methods, evidence on practical applications, and ethical concerns are included in this review. However, appropriate guidelines and preparation protocols for its optimal use in a wide range of clinical applications have yet to be standardized. Baishideng Publishing Group Inc 2021-11-26 2021-11-26 /pmc/articles/PMC8641019/ /pubmed/34909120 http://dx.doi.org/10.4252/wjsc.v13.i11.1733 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
spellingShingle | Review Jeyaraman, Madhan Muthu, Sathish Sharma, Shilpa Ganta, Charan Ranjan, Rajni Jha, Saurabh Kumar Nanofat: A therapeutic paradigm in regenerative medicine |
title | Nanofat: A therapeutic paradigm in regenerative medicine |
title_full | Nanofat: A therapeutic paradigm in regenerative medicine |
title_fullStr | Nanofat: A therapeutic paradigm in regenerative medicine |
title_full_unstemmed | Nanofat: A therapeutic paradigm in regenerative medicine |
title_short | Nanofat: A therapeutic paradigm in regenerative medicine |
title_sort | nanofat: a therapeutic paradigm in regenerative medicine |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641019/ https://www.ncbi.nlm.nih.gov/pubmed/34909120 http://dx.doi.org/10.4252/wjsc.v13.i11.1733 |
work_keys_str_mv | AT jeyaramanmadhan nanofatatherapeuticparadigminregenerativemedicine AT muthusathish nanofatatherapeuticparadigminregenerativemedicine AT sharmashilpa nanofatatherapeuticparadigminregenerativemedicine AT gantacharan nanofatatherapeuticparadigminregenerativemedicine AT ranjanrajni nanofatatherapeuticparadigminregenerativemedicine AT jhasaurabhkumar nanofatatherapeuticparadigminregenerativemedicine |